Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency

Conway, GS; Szarras-Czapnik, M; Racz, K; Keller, Anita; Chanson, P; Tauber, M; Zacharin, M; 1369, GHD to GHDA Transition Study Group (2009). Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. European journal of endocrinology, 160(6), pp. 899-907. Bristol: BioScientifica Ltd. 10.1530/EJE-08-0436

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
UniBE Contributor:	Vuissoz, Jean-Marc
ISSN:	0804-4643
Publisher:	BioScientifica Ltd.
Language:	English
Submitter:	Anette van Dorland
Date Deposited:	04 Oct 2013 15:13
Last Modified:	05 Dec 2022 14:22
Publisher DOI:	10.1530/EJE-08-0436
Web of Science ID:	000272934600003
URI:	https://boris.unibe.ch/id/eprint/32402 (FactScience: 197559)